Medpace Holdings Inc (MEDP)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	374,854	383,504	384,845	365,425	326,486	287,814	253,005	234,461	217,399	214,615	206,259	192,662	179,208	182,871	165,511	169,950	159,879	158,162	155,370	143,700
Revenue (ttm)	US$ in thousands	1,899,742	1,816,339	1,717,384	1,607,723	1,488,796	1,387,029	1,289,052	1,216,138	1,145,156	1,094,017	1,028,823	955,525	926,439	896,133	881,998	891,107	860,969	823,198	786,213	742,253
Gross profit margin		19.73%	21.11%	22.41%	22.73%	21.93%	20.75%	19.63%	19.28%	18.98%	19.62%	20.05%	20.16%	19.34%	20.41%	18.77%	19.07%	18.57%	19.21%	19.76%	19.36%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $374,854K ÷ $1,899,742K
= 19.73%

The gross profit margin of Medpace Holdings Inc has exhibited a generally stable trend over the past eight quarters, ranging from 27.81% to 29.68%. There was a slight fluctuation in the margin, with Q2 and Q1 of 2023 showing higher margins compared to the preceding quarters. However, the margins in Q4 2022 and Q3 2022 were relatively consistent around the 29% mark. Overall, the company has been able to maintain healthy gross profit margins, indicating efficient cost management and pricing strategies in place. Further analysis of factors influencing the margins in each quarter could provide more insights into the company's performance and profitability.